| 期 |
标题 |
文件 |
| 卷 4, 编号 1 (2007) |
Primenenie zofenoprila u bol'nykh s infarktom miokarda |
|
|
Galyavich A.
|
| 卷 3, 编号 2 (2006) |
Primenenie ingibitorov angiotenzinprevrashchayushchego fermenta v lechenii arterial'noy gipertonii |
|
|
Galyavich A.
|
| 卷 2, 编号 2 (2005) |
Primenenie karvedilola u bol'nykh s metabolicheskim sindromom |
|
|
Mychka V., Chazova I.
|
| 卷 8, 编号 4 (2011) |
Primenenie neselektivnogo antagonista retseptorov endotelina bozentana u bol'nykh idiopaticheskoy legochnoy gipertenziey: pervyy rossiyskiy opyt i vzglyad v budushchee |
|
|
Martynyuk T., Arkhipova O., Kobal' E., Eruslanova K., Danilov N., Chazova I.
|
| 卷 13, 编号 3 (2016) |
Application of advanced electrovectorcardiographic methods in the diagnosis of left ventricular hypertrophy on the basis of Uryupinsk central district hospital |
(Rus)
|
|
Vishnyakova N., Ryabykina G., Sakhnova T., Blinova E., Kozhemiakina E., Volkov V.
|
| 卷 8, 编号 4 (2011) |
Primenenie preparata Dibikor u podrostkov s arterial'noy gipertenziey |
|
|
Ledyaev M., Zhukova V., Anan'eva Y.
|
| 卷 5, 编号 3 (2008) |
Primenenie RAVELa SR pri arterial'noy gipertenzii na fone ozhireniya |
|
|
Nedogoda S., Barykina I., Brel' U., Chalyabi T., Mazina G., Podol'skaya E., Zaremba D.
|
| 卷 11, 编号 4 (2014) |
The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches |
(Rus)
|
|
Gilyarevsky S., Kuzmina I., Golshmid M.
|
| 卷 9, 编号 1 (2012) |
Primenenie fiksirovannoy kombinatsii lizinoprila s amlodipinom u patsientov s arterial'noy gipertenziey |
|
|
Chazova I., Ratova L., Nedogoda S., Lopatin Y., Perepech N., Tsoma V.
|
| 卷 10, 编号 1 (2013) |
Priorities for choosing diuretics in the treatment of hypertensive disease: Evidence-based medicine, recommendation documents, and real clinical practice |
|
|
Kompaniets O., Averin E.
|
| 卷 11, 编号 2 (2014) |
The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience |
(Rus)
|
|
Gilyarevsky S.
|
| 卷 15, 编号 1 (2018) |
The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies |
(Rus)
|
|
Klimova A., Ambatello L., Smolyakova E., Nistor S., Zykov K., Chazova I.
|
| 卷 3, 编号 2 (2006) |
Protivoishemicheskoe, antiaritmicheskoe i sosudistoe deystvie ingibitora angiotenzinprevrashchayushchego fermenta zofenoprila v eksperimente |
|
|
Shlyakhto E., Galagudza M., Syrenskiy A., Blokhin I., Konstantinov I., Nifontov E.
|
| 卷 6, 编号 3 (2009) |
Contraindications and adverse events of drugs in cardioneurological patients. |
|
|
Kompaniets O.
|
| 卷 15, 编号 2 (2018) |
Stroke prevention in patients with atrial fibrillation and comorbidities |
(Rus)
|
|
Ostroumova O., Voevodina N., Guseva T., Pavleeva E., Piksina G., Goloborodova I.
|
| 卷 7, 编号 3 (2010) |
Profil' provospalitel'nykh markerov u patsientov s razlichnymi formami legochnoy gipertenzii |
|
|
Nakonechnikov S., Zykov K., Martynyuk T., Masenko V., Rvacheva A., Ratova L., Matvienko O., Andreeva Y., Chazova I.
|
| 卷 6, 编号 4 (2009) |
Direct renin inhibitors aliskiren - possibilities correction cardiorenal syndrome |
|
|
Chazova I., Fomin V.
|
| 卷 7, 编号 2 (2010) |
Pryamoy ingibitor renina aliskiren: novye gorizonty nefroprotektsii |
|
|
Villeval'de S., Troitskaya E., Kobalava Z.
|
| 卷 11, 编号 3 (2014) |
Psychosomatic Aspects of Low Adherence to Antihypertensive Therapy in Patients with Arterial Hypertension |
(Rus)
(Rus)
|
|
Fofanova T., Ageyev F., Kadushina E., Drobizhev M., Smirnova M., Kuzmina A.
|
| 卷 13, 编号 1 (2016) |
Pharmacological therapy, slows the heart rate, in patientswith hypertension and chronic heart failure: theory and application in clinical practice |
(Rus)
|
|
Ponomareva A., Kompaniets O., Linchak R., Ivanchura G.
|
| 卷 12, 编号 3 (2015) |
Radiofrequency denervation of renal arteries. Myth or reality? |
(Rus)
|
|
Grigin V., Danilov N., Matchin Y., Chazova I.
|
| 卷 17, 编号 1 (2020) |
Radiofrequency renal denervation with mono-electrode and multi-electrode device for treatment in patient with uncontrolled hypertension: results of a 6-month follow-up |
(Rus)
|
|
Agaeva R., Danilov N., Shchcelkova G., Matchin Y., Chazova I.
|
| 卷 15, 编号 4 (2018) |
Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension |
(Rus)
|
|
Agaeva R., Danilov N., Shelkova G., Sagaydak O., Grigin V., Matchin U., Chazova I.
|
| 卷 16, 编号 4 (2019) |
Radiofrequency denervation of the renal arteries in patients with resistant arterial hypertension: 3 years of observation experience |
(Rus)
|
|
Savelyeva N., Zherzhova A., Mikova E., Gapon L., Kolunin G., Krinochkin D.
|
| 卷 12, 编号 1 (2015) |
Radiofrequency renal arteries denervation: waiting for reply |
(Rus)
|
|
Grigin V., Danilov N., Matchin Y., Shelkova G., Chazova I.
|
| 卷 13, 编号 4 (2016) |
Radiofrequency renal arteries denervation: effectively and safely |
(Rus)
|
|
Grigin V., Danilov N., Matchin Y., Chazova I.
|
| 卷 11, 编号 4 (2014) |
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension |
(Rus)
|
|
Valieva Z., Valeeva E., Glukhova S., Martynyuk T., Chazova I.
|
| 卷 6, 编号 1 (2009) |
Ramipril - angiotensin converting enzyme ingibitor with a wide spectrum of therapeutic action |
|
|
Preobrazhenskiy, D., Preobrazhensky D., Vyshinskaja I., Vyshinskaya I.
|
| 卷 14, 编号 2 (2017) |
Prevalence of hypertension in military age males according to physical evaluation results |
(Rus)
|
|
Melnik M., Uvarovskaya B., Makson I., Ivanov A.
|
| 卷 10, 编号 4 (2013) |
The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District |
|
|
Chazova I., Trubacheva I., Zhernakova Y., Oshchepkova E., Serebriakova V., Kaveshnikov V., Karpov R.
|
| 卷 11, 编号 4 (2014) |
The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk |
(Rus)
|
|
Zhernakova Y., Kaveshnikov V., Serebriakova V., Trubacheva I., Oshepkova Y., Balahonova T., Karpov R., Chazova I.
|
| 卷 12, 编号 3 (2015) |
The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study) |
(Rus)
|
|
Oshchepkova E., Dolgusheva I., Zhernakova I., Chazova I., Shal'nova S., Iarovaia E., Rotar' O., Konradi A., Boitsov S.
|
| 卷 15, 编号 1 (2018) |
Prevalence, awareness and adherence to treatment of arterial hypertension: myths and reality |
(Rus)
|
|
Krivoshapova K., Tsygankova D., Barbarash O.
|
| 卷 15, 编号 1 (2018) |
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results |
(Rus)
|
|
Zhernakova Y., Chazova I., Oshchepkova E., Shalnova S., Konradi A., Rotar O., Yarovaya E., Shlyahto E., Boitsov S.
|
| 卷 18, 编号 2 (2021) |
Prevalence of risk factors for arterial hypertension among draft age youth |
(Rus)
|
|
Uvarovskaia B., Mel’nik M., Kniazeva S.
|
| 卷 11, 编号 1 (2014) |
Rational therapy of hypertension with concomitant ischemic heart disease |
(Rus)
|
|
Chukaeva I., Orlova N., Soloveva M.
|
| 卷 10, 编号 4 (2013) |
Rational pharmacotherapy of hypertension. Urapidil potential |
|
|
Morozova T., Andruschishina T., Shmarova D.
|
| 卷 6, 编号 1 (2009) |
Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome |
|
|
Mychka V., Chazova I., Mychka V., Chazova I.
|
| 卷 10, 编号 1 (2013) |
Real and potential benefits of third-generation calcium antagonists |
|
|
Kirichenko A.
|
| 卷 8, 编号 4 (2011) |
Regress subklinicheskogo porazheniya organov-misheney u bol'nykh gipertonicheskoy bolezn'yu na fone razlichnykh podkhodov k naznacheniyu kombinirovannoy antigipertenzivnoy terapii |
|
|
Bushmakina A., Koziolova N., Kovalevskaya N.
|
| 卷 13, 编号 1 (2016) |
Regulatory adaptive status in determining the effectivenessof bisoprololum and sotalolum in patients with hypertensive disease and ventricular arrhythmias |
(Rus)
|
|
Shubitidze I., Tregubov V., Pokrovsky V.
|
| 卷 16, 编号 3 (2019) |
Regulatory adaptive status in determining the effectiveness of lisinopril and fosinopril in patients with chronic heart failure with preserved left ventricular ejection fraction |
(Rus)
|
|
Nedvetskaia S., Shubitidze I., Tregubov V., Pokrovskiy V.
|
| 卷 13, 编号 4 (2016) |
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal atrial fibrillation |
(Rus)
|
|
Eremina M., Tregubov V., Pokrovsky V.
|
| 卷 14, 编号 4 (2017) |
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia |
(Rus)
|
|
Nazhalkina N., Tregubov V., Pokrovsky V.
|
| 卷 8, 编号 2 (2011) |
Regulyatorno-adaptivnyy statuspatsientov s gipertonicheskoybolezn'yu pri medikamentoznomdostizhenii tselevykh urovneyarterial'nogo davleniya |
|
|
Pokrovskiy V., Kompaniets O.
|
| 卷 15, 编号 3 (2018) |
Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment |
(Rus)
|
|
Aksenova A., Esaulova T., Sivakova O., Chazova I.
|
| 卷 17, 编号 1 (2020) |
Results of pulmonary thromboendarterectomy depending on different levels of pulmonary vascular resistance and angiographic index of the pulmonary artery lesion |
(Rus)
|
|
Gazizov V., Mershin K., Tabak’yan E., Partigulov S., Valieva Z., Martynyuk T., Akchurin R.
|
| 卷 11, 编号 3 (2014) |
The results of the open observational, international, multicenter, prospective program to assess the efficacy, safety and tolerability of the first direct renin inhibitor RasilezR (aliskiren) in patients with arterial hypertension in ‘real-life’ clinical practice settings (DRIve) |
(Rus)
|
|
Chazova I.
|
| 卷 5, 编号 2 (2008) |
Rezul'taty programmy «BazOvoe LEchenie i antigipertenzivnyy effekt: preparat Ravel SR u patsientov s arterial'nOy gipertoniey» (BOLERO) |
|
|
Glezer M., Saygitov R.
|
| 卷 7, 编号 1 (2010) |
Rezul'taty farmakoepidemiologicheskogo issledovaniya arterial'noy gipertonii PIFAGOR III |
|
|
Leonova M., Belousov D., Shteynberg L., Galitskiy A., Belousov Y.
|
| 卷 7, 编号 2 (2010) |
Rezul'taty farmakoepidemiologicheskogo issledovaniya arterial'noy gipertonii PIFAGOR III (opros patsientov s AG) |
|
|
Leonova M., Belousov Y., Shteynberg L., Galitskiy A., Belousov D.
|
| 卷 12, 编号 3 (2015) |
The results of the pharmacoepidemiological study PIFAGOR IV concerning arterial hypertension (AH patients survey) |
(Rus)
|
|
Leonova M., Belousov Y., Shteinberg L., Alimova E., Smirnova E., Belousov D.
|
| 卷 10, 编号 3 (2013) |
Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii |
|
|
Mancia G., Fagard R.
|
| 卷 10, 编号 4 (2013) |
Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii |
|
|
Mancia G., Fagard R.
|
| 卷 11, 编号 2 (2014) |
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders |
(Rus)
|
|
Zhernakova Y., Chazova I.
|
| 卷 5, 编号 3 (2008) |
Rekomendatsii po diagnostike i lecheniyu arterial'noy gipertonii 2008: chto novogo? |
|
|
Chazova I., Ratova L.
|
| 卷 15, 编号 3 (2018) |
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines] |
(Rus)
|
|
Chazova I., Zhernakova Y.
|
| 卷 14, 编号 2 (2017) |
Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) |
(Rus)
|
|
Marwick T., Gillebert T., Aurigemma G., Chirinos J., Derumeaux G., Galderisi M., Gottdiener J., Haluska B., Ofili E., Segers P., Senior R., Tapp R., Zamorano J., Khadzegova A., Matskeplishvili S., Krikunov P.
|
| 卷 18, 编号 3 (2021) |
Renal artery denervation in patients with resistant arterial hypertension: clinical and organ-protective effect |
(Rus)
|
|
Gapon L., Mikova E., Krinochkin D., Savelyeva N., Zherzhova A., Aleksandrovich E.
|
| 卷 6, 编号 1 (2009) |
Renovaskulyarnaya arterial'naya gipertenziya: diagnostika i lechenie |
|
|
Danilov N., Chazova I., Savchenko A.
|
| 卷 3, 编号 1 (2006) |
Restenoz posle koronarnogo stentirovaniya u bol'nykh s metabolicheskim sindromom |
|
|
Danilov N., Gorgadze T., Savchenko A., Chazova I.
|
| 卷 10, 编号 4 (2013) |
Riociguatas the first innovative guanylatecyclase stimulators class drugs for pulmonary arterial hypertension patients treatment |
|
|
Chazova I., Martynyuk T.
|
| 卷 11, 编号 1 (2014) |
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components |
(Rus)
|
|
Zhernakova Y., Sharipova G., Chazova I.
|
| 卷 12, 编号 1 (2015) |
The role of beta-blockers in the treatment of arterial hypertension: what do we know today |
(Rus)
|
|
Zhernakova Y., Chazova I.
|
| 卷 15, 编号 2 (2018) |
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment |
(Rus)
|
|
Arkhipova O., Martynyuk T.
|
| 卷 13, 编号 3 (2016) |
The role of bisoprolol in the management of patients with arterial hypertension |
(Rus)
|
|
Nedogoda S.
|
| 卷 6, 编号 1 (2009) |
The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan |
|
|
Baryshnikova G., Baryshnikova G.
|
| 卷 9, 编号 1 (2012) |
Rol' giperaktivnosti simpaticheskoy nervnoy sistemy v razvitii serdechno-sosudistykh zabolevaniy i vozmozhnosti farmakologicheskoy korrektsii |
|
|
Dorofeeva G., Dorofeev V., Trofimova Y.
|
| 卷 5, 编号 4 (2008) |
Rol' moksonidina v kombinirovannoy antigipertenzivnoy terapii patsientov s metabolicheskim sindromom |
|
|
Podzolkov V., Bragina A., Gladysheva E.
|
| 卷 11, 编号 3 (2014) |
The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects |
(Rus)
|
|
Gilyarevsky S.
|
| 卷 4, 编号 2 (2007) |
Rol' radionuklidnykh metodov issledovaniya pri arterial'noy gipertonii |
|
|
Samoylenko L., Sergienko V.
|
| 卷 9, 编号 2 (2012) |
Rol' sildenafila v lechenii bol'nykh legochnoy arterial'noy gipertenziey |
|
|
Martynyuk T., Chazova I.
|
| 卷 4, 编号 1 (2007) |
Rol' sutochnogo monitorirovaniya arterial'nogo davleniya v otsenke effektivnosti antigipertenzivnoy terapii (Rezul'taty sutochnogo monitorirovaniya arterial'nogo davleniya v programme KLIP-AKKORD) |
|
|
Chazova I., Ratova L.
|
| 卷 10, 编号 3 (2013) |
Rol' trimetazidina v regulyatsii energeticheskogo metabolizma miokarda pri serdechno-sosudistykh zabolevaniyakh |
|
|
Dorofeeva G., Dorofeev I., Trofimova Y., Manerova O.
|
| 卷 15, 编号 2 (2018) |
Blood pressure level and arterial stiffness parameters role in prediction of the antihypertensive therapy efficacy escape phenomenon |
(Rus)
|
|
Mikhailova O., Elfimova E., Litvin A., Rogoza A.
|
| 卷 12, 编号 4 (2015) |
The role of risk factors and endothelium dysfunction in the pathogenesis of the high normal arterial preassure and clinical signs of the vegetative disturbances in children |
(Rus)
|
|
Maksimovich N.
|
| 卷 16, 编号 4 (2019) |
Role of fixed combinations in modern treatment of arterial hypertension: new or well overlooked old? |
(Rus)
|
|
Adasheva T., Samorukova E., Zadionchenko V., Laricheva K.
|
| 卷 7, 编号 2 (2010) |
Rol' fraktalkina v patogeneze idiopaticheskoy legochnoy gipertenzii |
|
|
Nakonechnikov S., Zykov K., Martynyuk T., Masenko V., Chazova I.
|
| 卷 3, 编号 2 (2006) |
Rossiyskaya programma LIDER: otsenka izmeneniya kachestva zhizni boL'nykh Ishemicheskoy bolezn'yu serDtsa na fonE teRapii liprimarom |
|
|
Karpov Y., Deev A.
|
| 卷 8, 编号 2 (2011) |
Rossiyskie nablyudatel'nyeissledovaniya valsartanai kombinirovannoyantigipertenzivnoy terapiina ego osnove |
|
|
Karpov Y., Podzolkov V., Fomin V., Vigdorchik A.
|
| 卷 17, 编号 1 (2020) |
Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2 |
(Rus)
|
|
Chazova I., Shestakova M., Zhernakova Y., Markova T., Mazurina N., Yezhov M., Mironova O., Litvin A., Elfimova E., Blinova N., Sukhareva O., Ametov A., Akhmedzhanov N., Kislyak O., Kukharchuk V., Nedogoda S., Nebieridze D., Medvedev I., Mkrtumyan A., Podzolkov V.
|
| 卷 1, 编号 1 (2004) |
Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya) |
|
|
Chazova I.
|
| 卷 14, 编号 4 (2017) |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V |
(Rus)
|
|
Chazova I., Tyulyandin S., Vitsenia M., Poltavskaya M., Gilyarov M., Martynyuk T., Ovchinnikov A., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.
|
| 卷 15, 编号 1 (2018) |
Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI-VII |
(Rus)
|
|
Chazova I., Tyulyandin S., Vitsenia M., Panchenko E., Fedotkina Y., Poltavskaya M., Gilyarov M., Martynyuk T., Ovchinnikov A., Stenina M., Trophimova O., Ageev F.
|
| 卷 14, 编号 3 (2017) |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I |
(Rus)
|
|
Chazova I., Tyulyandin S., Vitsenia M., Ovchinnikov A., Poltavskaya M., Gilyarov M., Martynyuk T., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.
|
| 卷 1, 编号 2 (2004) |
Samokontrol' arterial'nogo davleniya patsientami povyshaet priverzhennost' k lecheniyu arterial'noy gipertonii (nablyudenie 1 god) |
|
|
Oshchepkova E., Tsagareishvili E., Rogoza A.
|
| 卷 5, 编号 3 (2008) |
Samostoyatel'noe izmerenie arterial'nogo davleniya v domashnikh usloviyakh |
|
|
Ratova L., Chazova I., Boytsov S.
|
| 卷 6, 编号 2 (2009) |
Sartans in cardiological practice: new possibilities in therapy of cardiovascular diseases |
|
|
Smolenskaya O.
|
| 卷 10, 编号 2 (2013) |
Sartans in the treatment of high-risk hypertension: the abilities of candesartan |
|
|
Morozova T.
|
| 卷 2, 编号 1 (2005) |
Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora? |
|
|
Shestakova M.
|
| 卷 15, 编号 4 (2018) |
The relationship between the antihypertensive effect of b-adrenergic blockers and the initial daily variability of sinus rhythm |
(Rus)
|
|
Sobolev A., Talabanov P., Ryabykina G., Kozhemyakina E.
|
| 卷 8, 编号 2 (2011) |
Svyaz' chisla komponentovmetabolicheskogo sindromas rasprostranennost'yui vyrazhennost'yu porazheniyaorganov-misheney |
|
|
Zhernakova Y., Chazova I., Mychka V., Olimpieva S., Kilikovskiy V.
|
| 卷 12, 编号 2 (2015) |
Cardioncology: management of arterial hypertension in patients with cancer on chemotherapy |
(Rus)
|
|
Chazova I., Oschepkova E., Kirillova M., Sharipova G.
|
| 卷 4, 编号 1 (2007) |
Simptomaticheskaya arterial'naya gipertoniya pri pervichnom i vtorichnom giperal'dosteronizme |
|
|
Chikhladze N., Chazova I.
|
| 卷 3, 编号 1 (2006) |
Sindrom obstruktivnogo apnoe vo vremya sna i arterial'naya gipertenziya |
|
|
Chazova I., Litvin A.
|
| 卷 6, 编号 1 (2009) |
Obstructive sleep apnea syndrome |
|
|
Litvin A., Chazova I., Litvin A., Chazova I.
|
| 卷 6, 编号 2 (2009) |
Obstructive sleep apnea syndrome |
|
|
Litvin A., Chazova I.
|
| 卷 10, 编号 3 (2013) |
Sindrom obstruktivnogo apnoe sna i disfunktsiya endoteliya |
|
|
Galitsin P., Aksenova A., Elfimova E., Ishankhodzhaeva G., Balakhonova T., Litvin A., Chazova I.
|
| 卷 15, 编号 2 (2018) |
Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion |
(Rus)
|
|
Litvin A., Elfimova E., Chazova I.
|
| 卷 8, 编号 1 (2011) |
Skoraya meditsinskaya pomoshch' pri povyshenii arterial'nogo davleniya. |
|
|
Ruksin V., Grishin O., Yashchenkova S., Onuchin M.
|
| 501 - 600 的 734 信息 |
<< < 1 2 3 4 5 6 7 8 > >> |
